{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:49:35Z","timestamp":1790401775716,"version":"4.1.0"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.actbio.2021.03.007","type":"journal-article","created":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T03:42:16Z","timestamp":1615261336000},"page":"144-153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Loss of sarcomeric proteins via upregulation of JAK\/STAT signaling underlies interferon-\u03b3-induced contractile deficit in engineered human myocardium"],"prefix":"10.1016","volume":"126","author":[{"given":"Ren-Zhi","family":"Zhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingjun","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4850-9549","authenticated-orcid":false,"given":"Zhaowei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1907-0925","authenticated-orcid":false,"given":"Nicholas","family":"Strash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5688-6061","authenticated-orcid":false,"given":"Nenad","family":"Bursac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.actbio.2021.03.007_bib0001","doi-asserted-by":"crossref","first-page":"16045","DOI":"10.1038\/nrdp.2016.45","article-title":"Sepsis and septic shock","volume":"2","author":"Hotchkiss","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.actbio.2021.03.007_bib0002","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.actbio.2021.03.007_bib0003","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.rdc.2010.02.002","article-title":"Cardiovascular complications of rheumatoid arthritis: assessment, prevention, and treatment","volume":"36","author":"Kaplan","year":"2010","journal-title":"Rheum. Dis. Clin. North Am."},{"key":"10.1016\/j.actbio.2021.03.007_bib0004","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.tcm.2016.07.006","article-title":"Cardiovascular disease in patients with rheumatoid arthritis","volume":"27","author":"Liao","year":"2017","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.actbio.2021.03.007_bib0005","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.rdc.2018.03.006","article-title":"Update on cardiovascular disease risk in patients with rheumatic diseases","volume":"44","author":"Mackey","year":"2018","journal-title":"Rheum. Dis. Clin. North Am."},{"key":"10.1016\/j.actbio.2021.03.007_bib0006","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0002-9343(02)01223-8","article-title":"Myocarditis in systemic lupus erythematosus","volume":"113","author":"Wijetunga","year":"2002","journal-title":"Am. J. Med."},{"key":"10.1016\/j.actbio.2021.03.007_bib0007","doi-asserted-by":"crossref","first-page":"483","DOI":"10.7326\/0003-4819-100-4-483","article-title":"Profound but reversible myocardial depression in patients with septic shock","volume":"100","author":"Parker","year":"1984","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.actbio.2021.03.007_bib0008","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2174\/157340311798220494","article-title":"Sepsis-induced cardiomyopathy","volume":"7","author":"Romero-Bermejo","year":"2011","journal-title":"Curr Cardiol Rev"},{"key":"10.1016\/j.actbio.2021.03.007_bib0009","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/CCM.0000000000002851","article-title":"Septic cardiomyopathy","volume":"46","author":"Beesley","year":"2018","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.actbio.2021.03.007_bib0010","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/0310057X1804600104","article-title":"Basic and advanced echocardiographic evaluation of myocardial dysfunction in sepsis and septic shock","volume":"46","author":"Vallabhajosyula","year":"2018","journal-title":"Anaesth. Intensive Care"},{"key":"10.1016\/j.actbio.2021.03.007_bib0011","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.chest.2018.08.1037","article-title":"The septic heart: current understanding of molecular mechanisms and clinical implications","volume":"155","author":"Martin","year":"2019","journal-title":"Chest"},{"key":"10.1016\/j.actbio.2021.03.007_bib0012","doi-asserted-by":"crossref","first-page":"42","DOI":"10.14797\/mdcj-8-1-42","article-title":"A case series of reversible acute cardiomyopathy associated with H1N1 influenza infection","volume":"8","author":"Barbandi","year":"2012","journal-title":"Methodist. Debakey Cardiovasc. J."},{"key":"10.1016\/j.actbio.2021.03.007_bib0013","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1001\/jama.2020.4326","article-title":"Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State","volume":"323","author":"Arentz","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.actbio.2021.03.007_bib0014","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.cca.2016.02.010","article-title":"Understanding the role of cytokines in the pathogenesis of rheumatoid arthritis","volume":"455","author":"Mateen","year":"2016","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.actbio.2021.03.007_bib0015","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1146\/annurev.immunol.15.1.749","article-title":"Cellular responses to interferon-gamma","volume":"15","author":"Boehm","year":"1997","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.actbio.2021.03.007_bib0016","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1086\/315155","article-title":"Elevated plasma concentrations of interferon (IFN)-gamma and the IFN-gamma-inducing cytokines interleukin (IL)-18, IL-12, and IL-15 in severe melioidosis","volume":"180","author":"Lauw","year":"1999","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.actbio.2021.03.007_bib0017","doi-asserted-by":"crossref","first-page":"46652","DOI":"10.1038\/srep46652","article-title":"Elevated circulating levels of the interferon-gamma-induced chemokines are associated with disease activity and cutaneous manifestations in adult-onset Still\u2019s disease","volume":"7","author":"Han","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.actbio.2021.03.007_bib0018","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13075-019-1878-y","article-title":"High levels of circulating interferons type I, type II and type III associate with distinct clinical features of active systemic lupus erythematosus","volume":"21","author":"Oke","year":"2019","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.actbio.2021.03.007_bib0019","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/infdis\/161.5.982","article-title":"Prognostic values of tumor necrosis factor\/cachectin, interleukin-1, interferon-alpha, and interferon-gamma in the serum of patients with septic shock. Swiss-Dutch J5 Immunoglobulin Study Group","volume":"161","author":"Calandra","year":"1990","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.actbio.2021.03.007_bib0020","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/01.CCM.0000104950.52577.97","article-title":"Plasma interferon-gamma and interleukin-10 concentrations in systemic meningococcal disease compared with severe systemic Gram-positive septic shock","volume":"32","author":"Bjerre","year":"2004","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.actbio.2021.03.007_bib0021","doi-asserted-by":"crossref","first-page":"592","DOI":"10.4049\/jimmunol.178.1.592","article-title":"An inflammatory pathway of IFN-gamma production in coronary atherosclerosis","volume":"178","author":"Ranjbaran","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.actbio.2021.03.007_bib0022","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1161\/CIRCULATIONAHA.108.827618","article-title":"Interleukin-17 and interferon-gamma are produced concomitantly by human coronary artery-infiltrating T cells and act synergistically on vascular smooth muscle cells","volume":"119","author":"Eid","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.actbio.2021.03.007_bib0023","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1080\/22221751.2020.1770129","article-title":"Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors","volume":"9","author":"Han","year":"2020","journal-title":"Emerg. Microbes Infect."},{"issue":"2","key":"10.1016\/j.actbio.2021.03.007_bib0024","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s10741-013-9393-8","article-title":"Could interferon-gamma be a therapeutic target for treating heart failure?","volume":"19","author":"Levick","year":"2014","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.actbio.2021.03.007_bib0025","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2353\/ajpath.2007.060906","article-title":"Interferon-gamma induces chronic active myocarditis and cardiomyopathy in transgenic mice","volume":"171","author":"Reifenberg","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.actbio.2021.03.007_bib0026","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.cyto.2005.06.013","article-title":"Inhibitory effects of interferon-gamma on myocardial hypertrophy","volume":"31","author":"Jin","year":"2005","journal-title":"Cytokine"},{"key":"10.1016\/j.actbio.2021.03.007_bib0027","doi-asserted-by":"crossref","first-page":"H587","DOI":"10.1152\/ajpheart.00298.2012","article-title":"Interferon-gamma ablation exacerbates myocardial hypertrophy in diastolic heart failure","volume":"303","author":"Garcia","year":"2012","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.actbio.2021.03.007_bib0028","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.008145","article-title":"Protective roles of interferon-gamma in cardiac hypertrophy induced by sustained pressure overload","volume":"7","author":"Kimura","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.actbio.2021.03.007_bib0029","first-page":"49","article-title":"Gamma-interferon-induced cardiomyopathy during treatment of renal cell carcinoma: a case report","volume":"36","author":"Morino","year":"2000","journal-title":"J. Cardiol."},{"key":"10.1016\/j.actbio.2021.03.007_bib0030","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1600-0463.2010.02705.x","article-title":"Multiplex cytokine profiling in patients with sepsis","volume":"119","author":"Mera","year":"2011","journal-title":"APMIS"},{"issue":"3","key":"10.1016\/j.actbio.2021.03.007_bib0031","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1128\/IAI.71.3.1185-1193.2003","article-title":"Evidence that development of severe cardiomyopathy in human Chagas' disease is due to a Th1-specific immune response","volume":"71","author":"Gomes","year":"2003","journal-title":"Infect. Immun."},{"key":"10.1016\/j.actbio.2021.03.007_bib0032","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1161\/CIRCRESAHA.115.307778","article-title":"Revisiting cardiac cellular composition","volume":"118","author":"Pinto","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.actbio.2021.03.007_bib0033","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nprot.2012.150","article-title":"Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt\/\u03b2-catenin signaling under fully defined conditions","volume":"8","author":"Lian","year":"2013","journal-title":"Nat. Protoc."},{"issue":"23","key":"10.1016\/j.actbio.2021.03.007_bib0034","doi-asserted-by":"crossref","first-page":"5813","DOI":"10.1016\/j.biomaterials.2013.04.026","article-title":"Tissue-engineered cardiac patch for advanced functional maturation of human ESC-derived cardiomyocytes","volume":"34","author":"Zhang","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2021.03.007_bib0035","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1038\/s41467-017-01946-x","article-title":"Cardiopatch platform enables maturation and scale-up of human pluripotent stem cell-derived engineered heart tissues","volume":"8","author":"Shadrin","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.actbio.2021.03.007_bib0036","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.biomaterials.2016.09.024","article-title":"Dynamic culture yields engineered myocardium with near-adult functional output","volume":"111","author":"Jackman","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2021.03.007_bib0037","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nature22978","article-title":"The extracellular matrix protein agrin promotes heart regeneration in mice","volume":"547","author":"Bassat","year":"2017","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.actbio.2021.03.007_bib0038","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.stem.2012.09.013","article-title":"Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes","volume":"12","author":"Tohyama","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.actbio.2021.03.007_bib0039","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1172\/JCI117956","article-title":"Interleukin-1 beta induces cardiac myocyte growth but inhibits cardiac fibroblast proliferation in culture","volume":"95","author":"Palmer","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.actbio.2021.03.007_bib0040","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/jcp.20307","article-title":"Role of interleukin-6 in cardiomyocyte\/cardiac fibroblast interactions during myocyte hypertrophy and fibroblast proliferation","volume":"204","author":"Fredj","year":"2005","journal-title":"J. Cell. Physiol."},{"issue":"7662","key":"10.1016\/j.actbio.2021.03.007_bib0041","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nature22978","article-title":"The extracellular matrix protein agrin promotes heart regeneration in mice","volume":"547","author":"Bassat","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.actbio.2021.03.007_bib0042","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.actbio.2018.08.003","article-title":"Long-term contractile activity and thyroid hormone supplementation produce engineered rat myocardium with adult-like structure and function","volume":"78","author":"Jackman","year":"2018","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2021.03.007_bib0043","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.biomaterials.2018.01.002","article-title":"Engineered cardiac tissue patch maintains structural and electrical properties after epicardial implantation","volume":"159","author":"Jackman","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2021.03.007_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.119824","article-title":"Lack of Thy1 defines a pathogenic fraction of cardiac fibroblasts in heart failure","volume":"236","author":"Li","year":"2020","journal-title":"Biomaterials"},{"issue":"12","key":"10.1016\/j.actbio.2021.03.007_bib0045","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/s41551-018-0290-2","article-title":"Incorporation of macrophages into engineered skeletal muscle enables enhanced muscle regeneration","volume":"2","author":"Juhas","year":"2018","journal-title":"Nat. Biomed. Eng."},{"issue":"4","key":"10.1016\/j.actbio.2021.03.007_bib0046","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1093\/cvr\/cvp164","article-title":"Cardiac fibroblast paracrine factors alter impulse conduction and ion channel expression of neonatal rat cardiomyocytes","volume":"83","author":"Pedrotty","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.actbio.2021.03.007_bib0047","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.biomaterials.2018.08.058","article-title":"Electrical stimulation increases hypertrophy and metabolic flux in tissue-engineered human skeletal muscle","volume":"198","author":"Khodabukus","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2021.03.007_bib0048","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/00001756-199512000-00014","volume":"7","author":"Charriaut-Marlangue","year":"1995","journal-title":"Neuroreport"},{"key":"10.1016\/j.actbio.2021.03.007_bib0049","first-page":"1465","article-title":"In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: a cautionary note","volume":"21","author":"Grasl-Kraupp","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.actbio.2021.03.007_bib0050","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1046\/j.1365-2249.1998.00664.x","article-title":"A variety of cytokines and immunologically relevant surface molecules are expressed by normal human skeletal muscle cells under proinflammatory stimuli","volume":"113","author":"Nagaraju","year":"1998","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.actbio.2021.03.007_bib0051","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.immuni.2009.09.002","article-title":"Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases","volume":"31","author":"Hu","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.actbio.2021.03.007_bib0052","doi-asserted-by":"crossref","first-page":"E6867","DOI":"10.1073\/pnas.1706915114","article-title":"Interferon-\u03b3 is a master checkpoint regulator of cytokine-induced differentiation","volume":"114","author":"Zha","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.actbio.2021.03.007_bib0053","first-page":"tr8","article-title":"The Jak-STAT pathway stimulated by interferon gamma","volume":"2004","author":"Horvath","year":"2004","journal-title":"Sci. STKE"},{"key":"10.1016\/j.actbio.2021.03.007_bib0054","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1002\/pro.3519","article-title":"The molecular details of cytokine signaling via the JAK\/STAT pathway","volume":"27","author":"Morris","year":"2018","journal-title":"Protein Sci."},{"key":"10.1016\/j.actbio.2021.03.007_bib0055","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1124\/jpet.113.209304","article-title":"Preclinical to clinical translation of tofacitinib, a Janus kinase inhibitor, in rheumatoid arthritis","volume":"348","author":"Dowty","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.actbio.2021.03.007_bib0056","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1002\/jcph.354","article-title":"The pharmacokinetics, pharmacodynamics, and safety of baricitinib, an oral JAK 1\/2 inhibitor, in healthy volunteers","volume":"54","author":"Shi","year":"2014","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.actbio.2021.03.007_bib0057","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1126\/science.1496401","article-title":"Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor","volume":"257","author":"Schindler","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.actbio.2021.03.007_bib0058","doi-asserted-by":"crossref","first-page":"13925","DOI":"10.1074\/jbc.R116.774745","article-title":"Current prospects of type II interferon gamma signaling and autoimmunity","volume":"292","author":"Green","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.actbio.2021.03.007_bib0059","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/jcpt.13142","article-title":"Comparative efficacy and safety of tofacitinib, baricitinib, upadacitinib, filgotinib and peficitinib as monotherapy for active rheumatoid arthritis","volume":"45","author":"Lee","year":"2020","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.actbio.2021.03.007_bib0060","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.tips.2020.06.007","article-title":"Targeting JAK-STAT signaling to control cytokine release syndrome in COVID-19","volume":"41","author":"Luo","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.actbio.2021.03.007_bib0061","doi-asserted-by":"crossref","first-page":"6008","DOI":"10.3390\/ijms20236008","article-title":"Cytokines in inflammatory disease","volume":"20","author":"Kany","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.actbio.2021.03.007_bib0062","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1016\/j.ajpath.2012.08.040","article-title":"Interferon-gamma causes cardiac myocyte atrophy via selective degradation of myosin heavy chain in a model of chronic myocarditis","volume":"181","author":"Cosper","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.actbio.2021.03.007_bib0063","doi-asserted-by":"crossref","first-page":"14336","DOI":"10.1074\/jbc.275.19.14336","article-title":"Hybrid proteasomes. Induction by interferon-gamma and contribution to ATP-dependent proteolysis","volume":"275","author":"Tanahashi","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.actbio.2021.03.007_bib0064","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1093\/emboj\/21.11.2636","article-title":"Properties of the hybrid form of the 26S proteasome containing both 19S and PA28 complexes","volume":"21","author":"Cascio","year":"2002","journal-title":"EMBO J."},{"key":"10.1016\/j.actbio.2021.03.007_bib0065","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.cell.2010.07.036","article-title":"Immunoproteasomes preserve protein homeostasis upon interferon-induced oxidative stress","volume":"142","author":"Seifert","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.actbio.2021.03.007_bib0066","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1177\/0003319717709380","article-title":"Systemic inflammation and arrhythmogenesis: a review of mechanistic and clinical perspectives","volume":"69","author":"Yalta","year":"2018","journal-title":"Angiology"},{"key":"10.1016\/j.actbio.2021.03.007_bib0067","first-page":"1717","article-title":"Systemic inflammation and arrhythmic risk: lessons from rheumatoid arthritis","volume":"38","author":"Lazzerini","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.actbio.2021.03.007_bib0068","doi-asserted-by":"crossref","first-page":"24691","DOI":"10.1073\/pnas.2006764117","article-title":"Distinct hypertrophic cardiomyopathy genotypes result in convergent sarcomeric proteoform profiles revealed by top-down proteomics","volume":"117","author":"Tucholski","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.actbio.2021.03.007_bib0069","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1242\/jeb.124941","article-title":"The sarcomeric cytoskeleton: from molecules to motion","volume":"219","author":"Gautel","year":"2016","journal-title":"J. Exp. Biol."},{"key":"10.1016\/j.actbio.2021.03.007_bib0070","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1073\/pnas.1612681114","article-title":"alpha-Actinin\/titin interaction: a dynamic and mechanically stable cluster of bonds in the muscle Z-disk","volume":"114","author":"Grison","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.actbio.2021.03.007_bib0071","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.bbrc.2011.06.047","article-title":"Controlling nuclear JAKs and STATs for specific gene activation by IFNgamma","volume":"410","author":"Noon-Song","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.actbio.2021.03.007_bib0072","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1126\/science.1281555","article-title":"Activation of transcription by IFN-gamma: tyrosine phosphorylation of a 91-kD DNA binding protein","volume":"258","author":"Shuai","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.actbio.2021.03.007_bib0073","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1038\/sj.onc.1203524","article-title":"Jak-Stat signal transduction pathway through the eyes of cytokine class II receptor complexes","volume":"19","author":"Kotenko","year":"2000","journal-title":"Oncogene"},{"issue":"23","key":"10.1016\/j.actbio.2021.03.007_bib0074","doi-asserted-by":"crossref","first-page":"9373","DOI":"10.1073\/pnas.0903487106","article-title":"Unphosphorylated STAT1 prolongs the expression of interferon-induced immune regulatory genes","volume":"106","author":"Cheon","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.actbio.2021.03.007_bib0075","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3109\/08977194.2011.614949","article-title":"JAKs go nuclear: emerging role of nuclear JAK1 and JAK2 in gene expression and cell growth","volume":"29","author":"Zouein","year":"2011","journal-title":"Growth Factor."},{"key":"10.1016\/j.actbio.2021.03.007_bib0076","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1186\/s12864-017-4058-y","article-title":"Canonical and non-canonical JAK\/STAT transcriptional targets may be involved in distinct and overlapping cellular processes","volume":"18","author":"Tsurumi","year":"2017","journal-title":"BMC Genomics"},{"key":"10.1016\/j.actbio.2021.03.007_bib0077","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.redox.2013.12.029","article-title":"The proteasome and the degradation of oxidized proteins: part III-Redox regulation of the proteasomal system","volume":"2","author":"Hohn","year":"2014","journal-title":"Redox. Biol."},{"key":"10.1016\/j.actbio.2021.03.007_bib0078","doi-asserted-by":"crossref","first-page":"e12697","DOI":"10.15252\/emmm.202012697","article-title":"G. Sacco Baricitinib Study, Mechanism of baricitinib supports artificial intelligence-predicted testing in COVID-19 patients","volume":"12","author":"Stebbing","year":"2020","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.actbio.2021.03.007_bib0079","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.cell.2020.04.035","article-title":"SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues","volume":"181","author":"Ziegler","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.actbio.2021.03.007_bib0080","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1093\/cvr\/cvaa191","article-title":"Single-cell analysis of SARS-CoV-2 receptor ACE2 and spike protein priming expression of proteases in the human heart","volume":"116","author":"Liu","year":"2020","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.actbio.2021.03.007_bib0081","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s10557-020-07071-0","article-title":"Inflammatory cytokines and chemokines as therapeutic targets in heart failure","volume":"34","author":"Hanna","year":"2020","journal-title":"Cardiovasc. Drugs Ther."}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706121001483?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706121001483?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T17:41:26Z","timestamp":1761673286000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706121001483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":81,"alternative-id":["S1742706121001483"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2021.03.007","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Loss of sarcomeric proteins via upregulation of JAK\/STAT signaling underlies interferon-\u03b3-induced contractile deficit in engineered human myocardium","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2021.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}